2018-2023 Global Overactive Bladder Treatment Consumption Market Report
NxtGen Reports recently added a new market research report in its offerings titled, "2018-2023 Global Overactive Bladder Treatment Consumption Market Report".
(EMAILWIRE.COM, September 11, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of global Overactive Bladder Treatment market for 2018-2023.
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
Over the next five years, this report projects that Overactive Bladder Treatment will register a 5.4% CAGR in terms of revenue, reach US$ 6460 million by 2023, from US$ 4710 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder Treatment market by product type, application, key manufacturers and key regions.
To calculate the market size, this report considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Anticholinergics
Mirabegron
Botox
Segmentation by application:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Overactive Bladder Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Overactive Bladder Treatment market by identifying its various subsegments.
Focuses on the key global Overactive Bladder Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Overactive Bladder Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Overactive Bladder Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-overactive-bladder-treatment
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
Contact Information:
Madhuri Vetal
NxtGen Reports
Email: sales@nxtgenreports.com
Phone: +918551022388
More Report at: https://www.nxtgenreports.com/market-research-reports
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
Over the next five years, this report projects that Overactive Bladder Treatment will register a 5.4% CAGR in terms of revenue, reach US$ 6460 million by 2023, from US$ 4710 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder Treatment market by product type, application, key manufacturers and key regions.
To calculate the market size, this report considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Anticholinergics
Mirabegron
Botox
Segmentation by application:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Overactive Bladder Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Overactive Bladder Treatment market by identifying its various subsegments.
Focuses on the key global Overactive Bladder Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Overactive Bladder Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Overactive Bladder Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-overactive-bladder-treatment
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
Contact Information:
Madhuri Vetal
NxtGen Reports
Email: sales@nxtgenreports.com
Phone: +918551022388
More Report at: https://www.nxtgenreports.com/market-research-reports
Contact Information:
NxtGen Reports
Madhuri Vetal
Tel: +918551022388
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
NxtGen Reports
Madhuri Vetal
Tel: +918551022388
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results